Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 2Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 27Colorectal Neoplasms 9Breast Neoplasms 9Urinary Bladder Neoplasms 4Lung Neoplasms 4Neoplasms 3Urinary Incontinence 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Stomach Neoplasms 1Prostate Cancer Patients 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Melanoma 1Lymphoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Disease 1Death 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1

Interventions

Trastuzumab 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1sargramostim 1aldesleukin 1Rosiglitazone 1Ritonavir 1Radiotherapy 1Interviews as Topic 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Follicular × Interviews as Topic × Genitourinary × Clear all
NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡